| Announce Date | 01/28/2026 |
| EPS Normalized Actual | $2.4 (Miss by $-0.11) |
| EPS GAAP Actual | $2.4 (Miss by $-0.11) |
| Revenue Actual | $1.75286B |
| Revenue Surprise | Beat by $1752.86M |
| Announce Date | 12/31/1969 (Pre-Market) |
| EPS Normalized Estimate | $ |
| EPS GAAP Estimate | $ |
| Revenue Estimate | $0B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Dec 2029 | 11.5715 | 1.77 | 11.5715 | 11.5715 | 1 |
| Dec 2028 | 11.2978 | 1.82 | 11.2978 | 11.2978 | 1 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ4 2025 (Dec 2025) | 2.48 | 2.48 | 1.75286B | 23.08% | 1752.86M |
| FQ3 2025 (Sep 2025) | 1.96 | 1.96 | 1.63456B | 9.71% | 1634.56M |
| FQ2 2025 (Jun 2025) | 1.41 | 1.41 | 1.49109B | 1.73% | 1491.09M |
| FQ1 2025 (Mar 2025) | 0.42 | 0.42 | 1.46903B | 3.49% | 1469.03M |
| FQ4 2024 (Dec 2024) | 0 | 0 | 1.34825B | 16.11% | 1348.25M |
| FQ3 2024 (Sep 2024) | 1.43 | 1.43 | 1.47586B | 100% | 1475.86M |
| FQ2 2024 (Jun 2024) | 1.59 | 1.59 | 1.46526B | 100% | 1465.26M |
| FQ1 2024 (Mar 2024) | 1.57 | 1.57 | 1.41769B | 100% | 1417.69M |
FQ4 Announce Date
12/31/1969 (Pre-Market)
Consensus EPS Estimates
Consensus Revenue Estimates
0B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2029 (Dec 2029) | 3.0907 | -- | 3.0907 | 3.0907 | 1 |
| FQ3 2029 (Sep 2029) | 2.9422 | -- | 2.9422 | 2.9422 | 1 |
| FQ2 2029 (Jun 2029) | 2.4357 | -- | 2.4357 | 2.4357 | 1 |
| FQ1 2029 (Mar 2029) | 2.7731 | -- | 2.7731 | 2.7731 | 1 |
| FQ4 2028 (Dec 2028) | 2.9697 | -- | 2.9697 | 2.9697 | 1 |
| FQ3 2028 (Sep 2028) | 2.8757 | -- | 2.8757 | 2.8757 | 1 |
| FQ2 2028 (Jun 2028) | 2.4005 | -- | 2.4005 | 2.4005 | 1 |
| FQ1 2028 (Mar 2028) | 2.8278 | -- | 2.8278 | 2.8278 | 1 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2029 (Dec 2029) | 1.94B | -- | 1.94B | 1.94B | 1 |
| FQ3 2029 (Sep 2029) | 1.91B | -- | 1.91B | 1.91B | 1 |
| FQ2 2029 (Jun 2029) | 1.76B | -- | 1.76B | 1.76B | 1 |
| FQ1 2029 (Mar 2029) | 1.68B | -- | 1.68B | 1.68B | 1 |
| FQ4 2028 (Dec 2028) | 1.83B | -- | 1.83B | 1.83B | 1 |
| FQ3 2028 (Sep 2028) | 1.8B | -- | 1.8B | 1.8B | 1 |
| FQ2 2028 (Jun 2028) | 1.65B | -- | 1.65B | 1.65B | 1 |
| FQ1 2028 (Mar 2028) | 1.6B | -- | 1.6B | 1.6B | 1 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
7
EPS # of Misses
0
EPS # of in-lines
1
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ4 2025 (Dec 2025) | 2.48 | 2.48 | 100% | |
| FQ3 2025 (Sep 2025) | 1.96 | 1.96 | 100% | |
| FQ2 2025 (Jun 2025) | 1.41 | 1.41 | 100% | |
| FQ1 2025 (Mar 2025) | 0.42 | 0.42 | 100% | |
| FQ4 2024 (Dec 2024) | 0 | 0 | NAN% | |
| FQ3 2024 (Sep 2024) | 1.43 | 1.43 | 100% | |
| FQ2 2024 (Jun 2024) | 1.59 | 1.59 | 100% | |
| FQ1 2024 (Mar 2024) | 1.57 | 1.57 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ4 2025 (Dec 2025) | $0B | $1.75B | $1752.86M | 100% |
| FQ3 2025 (Sep 2025) | $0B | $1.63B | $1634.56M | 100% |
| FQ2 2025 (Jun 2025) | $0B | $1.49B | $1491.09M | 100% |
| FQ1 2025 (Mar 2025) | $0B | $1.47B | $1469.03M | 100% |
| FQ4 2024 (Dec 2024) | $0B | $1.35B | $1348.25M | 100% |
| FQ3 2024 (Sep 2024) | $0B | $1.48B | $1475.86M | 100% |
| FQ2 2024 (Jun 2024) | $0B | $1.47B | $1465.26M | 100% |
| FQ1 2024 (Mar 2024) | $0B | $1.42B | $1417.69M | 100% |